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In this study we compared the eﬀects of two previously described antimitochondrial gold complexes, that is, [A] [Au(dppe)2]Cl
and [B] [Au(d4pype)2]Cl with two novel lipophilic cations, that is, [C] [Au(dpmaaH2)(dpmaaSnMe2)]Cl and [D]
[Au(dpmaaSnMe2)2]Cl as antimitochondrial agents. The results of this study indicate that [C] and [D] have intermediate par-
tition coeﬃcients and exhibited a selective uptake by cells. They exhibited a higher selectivity for the various cell lines than [A]
but were more cytotoxic than [B]. There is a signiﬁcant correlation between the cytotoxic potential of [A], [B], [C], and [D] and
their octanol/water partition coeﬃcients in both MCF-7 (breast cancer) and MCF-12A (nonmalignant breast) cells, whereas their
cytotoxic potential and ability to induce the release of cytochrome c correlated only in the case of the MCF-12A cells. Complexes
[C] and [D] are promising new chemotherapeutic drugs. These compounds target the mitochondrial membranes of certain can-
cer cells exploiting the diﬀerences between the mitochondrial membrane potential of these cells and normal cells. Although the
concentrations of these compounds necessary to eradicate cancer cells are very high, the results provide a basis for the synthesis of
a new family of compounds with intermediate partition coeﬃcients compared to [A] and [B] but with increased activity against
cancer cells.
Copyright © 2008 Sherika Mahepal et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
The successful chemotherapy of cancer has been hindered
by the acquired resistance of tumour cells to clinical drugs,
which has necessitated the use of multidrug therapy with a
higher potential for adverse drug eﬀects. The use of relatively
nonselective compounds results in the eradication of nor-
mal cells in addition to tumour cells. Previous studies have
indicated that [Au(dppe)2]Cl (see Figure 1) exhibits antitu-
mour activity in a wide range of tumour models in mice
[1]. Since the lipophilic cationic properties of [Au(dppe)2]Cl
promote its nonselective uptake into the mitochondria of all
cells, strategies were adopted to synthesize more hydrophilic
analogues that retained antitumour activity while being less
toxic to the mitochondria.
The lipophilicity of gold(I) phosphine complexes can be
controlled by an appropriate substitution at the quaternary
centre or alkyl backbone that enables the modiﬁcation of
the compound to achieve greater selectivity for tumour cells
[2]. This has led to the synthesis of the 3- and 4-pyridyl
s u b s t i t u t e da n a l o g u e so f[ A u ( d p p e ) 2]Cl by the replacement
of some or all of the phenyl substituents in dppe with hy-
drophilic pyridyl groups [3]. The lipophilicity of these tetra-
hedral bis(dipyridylphosphino) gold(I) complexes plays a
key role in determining their cellular uptake [4]. It is there-
fore necessary to retain the lipophilicity of the compound
within a certain octanol-water coeﬃcient range in order to
facilitate the uptake of a drug and determine the degree of
protein binding [2].
Although the precise mechanism of action of these gold-
containing lipophilic aromatic compounds is poorly under-
stood, several studies have suggested a mitochondrial mode
of action as well as the occurrence of DNA strand breaks and
DNA-protein crosslinks in tumour cells [1, 2, 4, 5].
Tumour cells possess one of the highest mitochondrial
transmembrane potentials [6, 7], which may be due to the
inability of tumour cells to use mitochondria to fulﬁl their
demands for ATP. Normal cells rely on oxygen consumption2 Metal-Based Drugs
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Figure 1: Structure of the experimental compounds: [Au(dppe)2]Cl [A], [Au(d4pype)2] C l[ B ] ,[ A u ( d p m a a S n M e 2)(dpmaaH2) ] C l[ C ] ,a n d
[Au(dpmaaSnMe2)2]Cl [D]. (50µM).
andoxidativephosphorylationforATPproductionthattakes
place in the mitochondria, whereas tumour cells rely pri-
marily on glycolysis for ATP production that takes place in
the cytosol of the cell [4]. Lipophilic cations that possess a
positive charge are able to penetrate the hydrophobic barri-
ers of the plasma and mitochondrial membranes [8]. These
compounds accumulate in the mitochondria in response to
a negative transmembrane potential, which is the rationale
behind the use of lipophilic cations as anticancer agents.
According to Davis et al. the uptake of a lipophilic cation
is dependent on both the plasma and mitochondrial mem-
brane potentials. The plasma membrane preconcentrates the
drug in the cytoplasm and the mitochondrial membrane,
in turn, concentrates the drug within the mitochondria [9].
These facts provide the perfect opportunity for drug accu-
mulation in tumour cells and the feasibility for the use of
tumour selective antimitochondrial compounds in human
cancer chemotherapy.
The [Au(d4pype)2]Cl complex (see Figure 1), which is
hydrophilic, exhibited a higher tumour uptake and a smaller
in vivo liver/tumour ratio in treated mice with advanced
Colon 38 adenocarcinoma tumours than [Au(dppe)2]Cl
[10]. McKeage et al. [4] corroborated that compounds
with an intermediate lipophilicity when compared to more
lipophilic or hydrophilic compounds displayed signiﬁcant
antitumour activity, less dose-limiting toxicity, and a higher
plasma concentration of gold. A correlation between the
lipophilicity of the drug and the degree of selectivity and cy-
totoxic potency of the compounds has been established [10].
This denotes that an enhanced selectivity is achieved with
greater hydrophilicity but an increase in the potency of the
drug can be observed with a greater lipophilicity.
The common occurrence of drug-resistant tumour cells
and the lack of selectivity of cancer drugs in diﬀeren-
tiating between tumour cells and normal cells are two
overriding problems in cancer chemotherapy [10]. In an
attempt to combat this lack of selectivity, an investiga-
tion was initiated into two new aromatic cations, that
is, [Au(dpmaaSnMe2)(dpmaaH2)]Cl [C] and [Au(dpmaa-
SnMe2)2]Cl[D](seeFigure 1).Thesimultaneouspresenceof
gold and tin in aromatic cations should oﬀer the advantage
of reducing the development of resistance in cancer cells.
2. MATERIALS AND METHOD
2.1. Octanol/waterpartitioncoefﬁcient
60µMs t o c ks o l u t i o n so f[ A u ( d p p e ) 2]Cl [A], Au(d4pype)2]-
Cl [B], [Au(dpmaaSnMe2)(dpmaaH2)]Cl [C], andSherika Mahepal et al. 3
[Au-(dpmaaSnMe2)2]Cl [D] were prepared in octanol
(Merck, Darmstadt, Germany). Water-saturated octanol and
octanol-saturated water were prepared by shaking equal
volumes of octanol and water for 15 minutes and allowing
the mixture to separate into the respective phases for 20
hours. The absorbance of the initial drug concentration in
the water-saturated octanol at 20µM, 40µM, and 60µM
was analysed by UV spectrophotometry. Five millilitres
of the octanol-saturated water were then added to 5ml
of the drug/octanol solutions to obtain a ﬁnal volume
of 10ml. These solutions were shaken vigorously for 15
minutes, thereafter they were left to separate into an octanol
and aqueous phase for 20 hours. The aqueous phase was
separated ensuring that there was no contamination from
the octanol phase, and each of these solutions was analysed
by UV spectrophotometry in 1cm quartz cuvettes to obtain
the absorbance of the compounds.
2.2. Cellcultures
Cytotoxicity assays were performed on the follow-
ing cell cultures: human ovarian carcinoma (A2780)-
(ECACC93112519) and its cisplatin-resistant subline (A-
2780cis)(ECACC93112517), breast carcinoma (MCF-7)-
(HTB-22), colon cancer (CoLo 320 DM)(CCL-220), cer-
vical carcinoma cells (HeLa)(CCL-2), mouse melanoma
(B16)(ECACC92101203), primary human ﬁbroblasts
(CCL-171), and a breast nontumourogenic cell line (MCF-
12A)(CRL-10782). A2780, A2780cis and CoLo 320 DM
were maintained in RPMI; B16, HeLa cells, and the primary
ﬁbroblasts were maintained in EMEM. B16 cells were
maintained in DMEM. MCF-7 cells were maintained in
DMEM supplemented with 2% nonessential amino acids
and MCF-12A cells were maintained in a 1 : 1 mixture
of DMEM and HAMS F12 medium with hydrocortisone
(10mg/mL), cholera toxin (1mg/mL), insulin (20mg/mL),
10% foetal calf serum (FCS), and epidermal growth factor
(100mg/mL). All media were supplemented with 1% solu-
tion of penicillin and streptomycinand 10% heat inactivated
FCS.
2.3. Cellgrowthassay
A metabolic assay based on the reactivity of MTT (3-[4,
5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide),
originally described by Mosmann [11] with modiﬁcations
[12], was used to determine the eﬀects of the experimental
compounds on cell growth after a 7-day treatment period in
96 well-round bottom microtiter plates.
2.4. Cellularuptakeofgold
MCF-7 and MCF-12A cells were prepared in supplemented
DMEM at a stock concentration of 5×106 cells/mL. The cells
were exposed to the various compounds at concentrations
that lead to 80–90% of cell death in the above-mentioned
assay for 30 minutes at 37
◦C, centrifuged for 10 minutes at
185g, and the pellets washed with Hank’s balanced salt solu-
tion (HBSS). The gold content of the pellets was determined
Table 1: Average octanol/water partition coeﬃcients of the experi-
mental compounds as well as the mean log octanol/water partition
coeﬃcient ± standard error mean (SEM).
Octanol/water partition coeﬃcient and
mean log octanol/water partition coeﬃcient ± SEM
Experimental Average1 octanol/water Mean log octanol/water
compounds partition coeﬃcient partition coeﬃcient
value ± SEM
[A] 12.06 1.07 ±0.104
[B] 0.038 −1.568 ±0.149
[C] 2.3 −0.012 ±0.317
[D] 1.67 0.09 ±0.155
1Average of 9 experiments at three diﬀerent concentrations.
on an inductively coupled plasma mass spectrometer (ICP-
MS) using standard procedures.
2.5. Releaseofcytochromec
AsuspensionofMCF-7andMCF-12Acells(2×106 cells/mL)
was prepared in supplemented DMEM. The cells were ex-
posed to a concentration of the various compounds that lead
to 80–90% of cell death for 30 minutes at 37
◦C, centrifuged
for 10 minutes at 185g, and the pellets washed with HBSS
and assayed according to the manufacturers’ instructions for
cytochrome c using an assay kit (Sigma Chemical Co, St.
Louis, Mo, USA).
2.6. Statisticalanalysis
The Pearson correlation coeﬃcient (±95% conﬁdence inter-
val) was calculated and used to determine correlations be-
tween the various assay results.
3. RESULTS
3.1. Octanol/waterpartitioncoefﬁcient
The average octanol/water partition coeﬃcient values and
the mean log octanol/water partition coeﬃcient values are
summarised in Table 1. The results indicate that [A] has a
mean log octanol/water partition coeﬃcient of 1.07, mak-
ing it a lipophilic compound whereas [B] is hydrophilic with
a very low log octanol/water partition coeﬃcient of −1.57.
The octanol/water partition coeﬃcients of both [C] and [D]
(−0.012 and 0.09, resp.) are intermediate to that of [A] and
[B].
3.2. Cytotoxicityassays
The IC50 values of the compounds for the various cell lines
are summarised in Table 2.A l le i g h tc e l lc u l t u r e sw e r em o r e
sensitive to [A] than any of the other compounds tested. [B]
was more selective for certain cell types such as MCF-7. This
celllinewas8-9timesmoresensitiveforthiscompoundthan
the colon cancer cell line (CoLo 320DM) and the primary ﬁ-
broblast culture. [C] and [D] also exhibited some selectivity4 Metal-Based Drugs
Table 2: Mean drug concentration (µM) causing 50% cell death
(IC50)aftertreatmentofvariouscelllineswiththeﬁveexperimental
compounds.
Cell lines [A]1 [B] [C] [D]
MCF-7 2.31 20.327 5.33 6.508
MCF-12A 2.424 160 25.639 16.58
A2780 1.158 22.244 12.996 17.277
A2780cis 2.58 37.663 10 20
HeLa 1.407 63.793 11.476 12.264
CoLo 7.686 200 31.141 26.234
Primary ﬁbroblasts 0.887 170 11.874 8.046
B16 0.115 49.89 4.999 2.738
1Average of 3–5 experiments.
Table 3: Gold uptake (mg/L) by MCF-7 and MCF-12 [A] cells
treated with the experimental compounds.
Gold Uptake (mg/L)1
Cell lines [A] [B] [C] [D]
MCF-7 5.27 5.19 2.85 2.68
MCF-12A 6.51 6.83 3.3 2.63
1Average of 3 diﬀerent experiments.
for certain cell types viz [D] acted on the B16 cells at a con-
centration that was 9.5 times lower than what was necessary
to inhibit the growth of CoLo 320DM.
3.3. Cellularuptakeofexperimentalcompounds
The average amount of gold taken up by MCF-7 and MCF-
12A cells after treatment with the various experimental com-
pounds is summarised in Table 3. The cells treated with [A]
and [B] accumulated almost twice the percentage of gold
than cells treated with [C] and [D].
3.4. Releaseofcytochromec
The average percentage of cytochrome c release by MCF-7
a n dM C F - 1 2 Ac e l l si ss u m m a r i s e di nTable 4. The results
indicate that the outer membrane of mitochondria of cells
treated with [A] incurred the greatest amount of damage as
only 2-3% of the cells had undamaged mitochondrial mem-
branes after treatment. There were no signiﬁcant diﬀerences
between the sensitivity of the mitochondrial membranes of
MCF-7A and MCF-12A for the experimental drugs.
3.5. Pearson’scorrelationcoefﬁcient
(i) There is a signiﬁcant correlation (P<. 05) between the
cytotoxic potential of [A], [B], [C], and [D] and their oc-
tanol/water partition coeﬃcients in both MCF-7 and MCF-
12A cells.
(ii) There is a signiﬁcant correlation (P<. 05) between
thecytotoxicpotentialof[A],[B],[C]and[D]andtheirabil-
ity to induce the release of cytochrome c in MCF-12A cells.
Table 4: Mitochondria of MCF-7 and MCF-12A cells with undam-
aged membranes after treatment with experimental compounds.
Percentage mitochondria with undamaged membranes
calculated as the invert of the percentage cytochrome c release1
Cell line Untreated [A] [B] [C] [D]
MCF-7 60.75 3 61.75 39.5 41.0
MCF-12A 70.25 2.25 76.5 48.0 46.25
1Average of 3–5 experiments.
4. DISCUSSION
Results from this study have indicated that [B], [C], and
[D] have octanol/water partition coeﬃcients that are lower
than that of [A]. These compounds exhibit more selectivity
for diﬀerent cell types but are less intrinsically potent. The
lower octanol/water partition coeﬃcients facilitate the more
selective uptake of these compounds. On the other hand,
Berners-Price et. al. [13] described a related compound, that
is, [Au(dpmaaH2)2]Cl, to be hydrophilic with no signiﬁcant
activity against cancer cells indicating the important role ly-
pophilicity plays in the design of antitumour compounds.
Asigniﬁcantcorrelationbetweendruguptakeandtheoc-
tanol/water partition coeﬃcient of compounds has been es-
tablished [10]. Although [C] and [D] have intermediate par-
tition coeﬃcients we failed to obtain a signiﬁcant correlation
between drug uptake and the octanol/water partition coeﬃ-
cient.
McKeage et al. [4]a ﬃrmed that compounds with an in-
termediate lipophilicity displayed signiﬁcant antitumour ac-
tivity, less dose-limiting toxicity, and a higher plasma con-
centration of gold when compared to more lipophilic or hy-
drophilic compounds. Similarly, we found a signiﬁcant cor-
relation between lipophilicity and cytotoxicity. However, re-
sults from this study suggest that the cellular uptake of these
compoundsisnotdependentonthelipophilicityofthecom-
pound.
The mere fact that cytochrome c is being released indi-
cates that the cell will eventually undergo apoptosis. The un-
coupling of oxidative phosphorylation results in the swelling
ofthemitochondria[5],whichconsequentlycausestheouter
membrane of the mitochondria to rupture, leading to the
release of cytochrome c [7]. In this study, we found a sig-
niﬁcant correlation between lipophilicity and mitochondrial
damage only in the case of the nontumourogenic breast cell
line (MCF-12A) and not the breast cancer cell line (MCF-7)
indicating a possible selectivity of less lipophilic compounds
for mitochondrial cell membranes.
Furthermore, cytotoxicity results indicate that MCF-7 is
more sensitive than MCF-12A to [B], [C], and [D].
The results from this study suggest that [C] and [D] act
more selectively against a breast cancer and myeloma cell
line than [B] but possess less overall cytotoxicity compared
to [A], which is an important characteristic in selecting an-
ticancer agents. These compounds possess an intermediate
partition coeﬃcient compared to [A] and [B], which plays
an important role in their uptake by both normal and cancer
cells. Future work will include experimental studies to obtainSherika Mahepal et al. 5
a clear understanding of the mechanism of action of [C] and
[D] and the inﬂuence of tin in this regard. Although the high
IC50 values obtained with [C] and [D] against malignant cell
lines are not achievable in vivo, it provides a basis for the
synthesis of a new family of compounds with intermediate
partition coeﬃcients compared to [A] and [B] but increased
activity against cancer cells.
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